Lurex Bio, Inc.
PrivateLast Round
Seed Round
Aug 31, 2026
Total Funding Raised
$125,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lurex Bio, Inc. is a biotechnology company that develops non-viral, non-genetic immune engineering platforms designed to address tumor immune evasion.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lurex Bio, Inc. Comparables
Compare Lurex Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carmine Therapeutics | 72% | |
| Isosceles Pharmaceuticals | 71% | |
| Ciloa | 68% |
Lurex Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 31, 2026 | ||||
| Angel | Feb 5, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
$150K seed round completed.
- Feb 5, 2026
$125K raised in an Angel round.
Lurex Bio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Lurex Bio, Inc.'s valuation, stock price, and market status.
Is Lurex Bio, Inc. a public or private company?
Lurex Bio, Inc. is a private company.
What is the current stock price of Lurex Bio, Inc.?
Lurex Bio, Inc. is a private company with no public stock price. Caplight tracks Lurex Bio, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Lurex Bio, Inc. worth (valuation)?
Valuation information for Lurex Bio, Inc. is not publicly available.
Can I buy Lurex Bio, Inc. stock?
Lurex Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Lurex Bio, Inc.'s last funding round?
Lurex Bio, Inc.'s most recent funding round was Seed Round on August 31, 2026.
Who are the main investors in Lurex Bio, Inc.?
Investor information for Lurex Bio, Inc. is not publicly disclosed.
Will Lurex Bio, Inc. IPO soon?
No public IPO plans have been announced for Lurex Bio, Inc..
How can I track Lurex Bio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lurex Bio, Inc.'s secondary market activity and sign up for updates.